Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Assembly Biosciences (ASMB) Return on Capital Employed (2016 - 2025)

Assembly Biosciences has reported Return on Capital Employed over the past 11 years, most recently at 0.06% for Q4 2025.

  • Quarterly results put Return on Capital Employed at 0.06% for Q4 2025, up 67.0% from a year ago — trailing twelve months through Dec 2025 was 0.06% (up 67.0% YoY), and the annual figure for FY2025 was 0.09%, up 48.0%.
  • Return on Capital Employed for Q4 2025 was 0.06% at Assembly Biosciences, up from 0.41% in the prior quarter.
  • Over the last five years, Return on Capital Employed for ASMB hit a ceiling of 0.06% in Q4 2025 and a floor of 1.44% in Q3 2023.
  • Median Return on Capital Employed over the past 5 years was 0.72% (2024), compared with a mean of 0.77%.
  • Biggest five-year swings in Return on Capital Employed: plummeted -69bps in 2022 and later skyrocketed 74bps in 2024.
  • Assembly Biosciences' Return on Capital Employed stood at 0.65% in 2021, then plummeted by -52bps to 0.99% in 2022, then fell by -19bps to 1.18% in 2023, then surged by 38bps to 0.73% in 2024, then surged by 92bps to 0.06% in 2025.
  • The last three reported values for Return on Capital Employed were 0.06% (Q4 2025), 0.41% (Q3 2025), and 1.02% (Q2 2025) per Business Quant data.